Martha J. Carter, Chief Regulatory Officer at ALBIREO PHARMA, INC. (ALBO), sold 423 shares at $24.52 ($10K) on 2022-01-24, disclosed to the SEC on 2022-01-25.
Scheduled sale ($10k) by Chief Regulatory Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALBO | SELL | 2022-10-25 | $2K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $3K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $3K | — | Filing → |